The report compares India’s non-clinical drug approval framework with regulatory practices in the US, European Union, the UK ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
Thank you and good morning everyone. With me this morning with prepared remarks are Christopher Boerner, our board chair and chief executive officer, and David Elkins, our chief financial officer.